Matthew Orton

Royal Marsden NHS Foundation Trust

Papers

1

Total Citations

11

H-Index

1

About

Matthew Orton is a researcher at the forefront of applying machine learning to improve clinical decision-making in oncology, with a particular focus on prostate cancer. His most cited work, "Clinical application of machine learning models in patients with prostate cancer before prostatectomy" (2024, 11 citations), addresses a critical challenge in urological surgery: predicting extracapsular extension (ECE) before radical prostatectomy. Orton’s key contribution lies in rigorously comparing decision curve analysis (DCA) with traditional receiver operating characteristic (ROC) metrics for model evaluation, demonstrating that DCA offers superior clinical utility by weighing the benefits of accurate prediction against the harms of unnecessary intervention. This work directly supports surgeons in personalizing risk assessments, potentially reducing overtreatment and improving patient outcomes. While his citation count is still growing, Orton’s research is notable for bridging the gap between complex machine learning models and practical, bedside decision-making. His approach underscores a commitment to translational medicine, ensuring that advanced analytics translate into tangible benefits for prostate cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Clinical application of machine learning models in patients with prostate cancer before prostatectomy
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Royal Marsden NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago